Experimental hut evaluation of linalool spatial repellent agar gel against <em>Anopheles gambiae</em> <em>sensu</em> <em>stricto</em> mosquitoes in a... (Publications)
BackgroundMalaria vector control is in need of new tools to face its current challenges such as the spread of pyrethroid-resistance and the increase of outdoor feeding mosquitoes. New strategies such as
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African... (Publications)
group (52%). About 14/16 patients with encephalopathic syndrome of the coma type were infected with malaria. Patients with psychotic reactions or abnormal psychiatric behaviour (3/38) and one patient who died
Costs and cost-effectiveness of vector control in Eritrea using insecticide-treated bed nets (Publications)
BACKGROUND: While insecticide-treated nets (ITNs) are a recognized effective method for preventing malaria, there has been an extensive debate in recent years about the best large-scale implementation strategy
Prévalence, diversité antigénique et multiplicité d'infections de <em>Plasmodium falciparum</em> en milieu scolaire au centre de la Côte... (Publications)
Multiplicity of P. falciparum infection was investigated in 196 children (46.2%). The prevalence of malaria was 54.7% based on light microscopy and 83.9% based on PCR. Genotyping based on polymorphism in the
Time of exposure and assessment influence the mortality induced by insecticides against metabolic resistant mosquitoes (Publications)
BACKGROUND: Increasing metabolic resistance in malaria vector mosquitoes resulted in the development of insecticide-treated nets (ITNs) with active ingredients (AI) that target them. Bioassays that accurately
Clinical Short Courses for Health Professionals at Swiss TPH (Page)
https://www.swisstph.ch/en/study-with-us/postgraduate/clinical-short-courses
the biology and epidemiology, detection methods and clinical aspects of tropical parasites such as malaria, intestinal protozoa or helminths. Location Duration Course Language More information Allschwil, [...] and tropical medicine, including health risks for travellers, recommended vaccinations and current malaria prophylaxis. Location Duration Course Language More information Hybrid: Allschwil, Switzerland and [...] during and after travel, with a special focus on tropical diseases Diagnosing...
Nicolaus Lorenz: Dedicated to Improving People's Health (Page)
https://www.swisstph.ch/en/news/20160601-nicolaus-lorenz-dedicated-to-improving-peoples-health
mandates; the most recent example being the investment framework for malaria eradication 2016–2030 (Action and Investment for Malaria Eradication – AIM) that was successfully launched in autumn 2015 and
Epidemiologist and Health Expert Marcel Tanner Receives Honorary Doctorate from the University of Zurich (News)
https://www.swisstph.ch/en/news/news-detail/news/epidemiologist-and-health-expert-marcel-tanner-receives-honorary-doctorate-from-the-university-of-zurich
to numerous research projects in the epidemiology and control of infectious diseases (especially malaria). In addition, on behalf of the SDC, he managed major health programmes and research projects in [...] in rural and urban areas of Tanzania and Chad. He was instrumental in the development of malaria vaccines (SPf66, RTS,S) for Africa. From 1996-1997 and 2009-2010, Marcel Tanner has been a regular lecturer
Arthropod Facility | Swiss TPH Research Infrastructure (Page)
https://www.swisstph.ch/en/research/research-infrastructure/arthropod-facility
important vectors because they spread some of the most devastating infectious diseases, such as malaria and dengue fever. To study the biology of arthropod vectors and to develop new tools for vector control
Defining health research for development: the perspective of stakeholders from an international health research partnership in Ghana and Tanzania (Publications)
GlaxoSmithKline (GSK, Vaccine Developer) and the global health nonprofit organisation PATH and its Malaria Vaccine Initiative program (PATH/MVI, Funder-Development Partner), (RTS, S) (NCT00866619). The r